Nonmedical use of prescription drugs

Obstetrics and Gynecology

Volumn 120, Issue 4, 2012, Pages 977-982

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALCOHOL; AMPHETAMINE DERIVATIVE; ANESTHETIC AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; BUPRENORPHINE; CENTRAL STIMULANT AGENT; CODEINE; DEXTROPROPOXYPHENE; FENTANYL; HYDROCODONE; HYDROMORPHONE; IBUPROFEN; KETAMINE; METHADONE; METHAMPHETAMINE; METHYLPHENIDATE; MORPHINE; NALOXONE; OPIATE; OXYCODONE; PARACETAMOL; PRESCRIPTION DRUG; SEDATIVE AGENT; TRAMADOL; TRANQUILIZER;

ABDOMINAL PAIN; AGITATION; ALCOHOL CONSUMPTION; ALCOHOLISM; ANALGESIA; ANXIETY DISORDER; ASSISTED VENTILATION; ATTENTION DEFICIT DISORDER; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM DEPRESSION; COGNITIVE DEFECT; DRUG ABUSE; DRUG BINDING; DRUG DEPENDENCE; DRUG FATALITY; DRUG FORMULATION; DRUG OVERDOSE; DRUG SCREENING; DRUG STORAGE; DRUG TRANSPORT; DRUG USE; EUPHORIA; GASTROINTESTINAL HEMORRHAGE; HEART ARRHYTHMIA; HUMAN; HYPERTENSION; LABORATORY TEST; LIVER FAILURE; LIVER INJURY; MENTAL DISEASE; METHAMPHETAMINE DEPENDENCE; MORPHINE ADDICTION; NARCOLEPSY; NEUROLOGIC DISEASE; OPIATE ADDICTION; PAIN; PATIENT EDUCATION; PATIENT REFERRAL; PHYSICAL EXAMINATION; PHYSICIAN; PREGNANT WOMAN; PRENATAL CARE; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; PSYCHOMOTOR DISORDER; PSYCHOSIS; QUESTIONNAIRE; RESPIRATION DEPRESSION; REVIEW; RHABDOMYOLYSIS; RISK FACTOR; SEDATION; SIDE EFFECT; TACHYCARDIA; URINARY TRACT DISEASE;

EID: 84866921541     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3182723b5a     Document Type: Review

References (31)

1. Substance Abuse and Mental Health Services Administration. Results from the 2010 National Survey on Drug Use and Health: summary of national findings, NSDUH Series H-41, HHS Publication No. (SMA) 11-4658. Rockville (MD): SAMHSA; 2011. Available at: http://www.samhsa. gov/data/NSDUH/2k10Results/Web/PDFW/ 2k10Results. pdf. Retrieved June 14, 2012.
2. CDC grand rounds: prescription drug overdoses - a U.S. epidemic. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep 2012;61:10-3.
3. National Institute on Drug Abuse. Prescription drugs: abuse and addiction. Research Report Series. Bethesda (MD): NIDA; 2011. Available at: http://www.drugabuse.gov/sites/default/files/rrprescription.pdf. Retrieved June 14, 2012.
4. American Society of Addiction Medicine. Public policy statement: short definition of addiction. Chevy Chase (MD): ASAM; 2011. Available at: http://www.asam.org/docs/publicy-policy-statements/1definition-of-addiction- short-4-11.pdf?sfvrsn=0. Retrieved June 14, 2012.
5. Cotto JH, Davis E, Dowling GJ, Elcano JC, Staton AB, Weiss SR. Gender effects on drug use, abuse, and dependence: a special analysis of results from the National Survey on Drug Use and Health. Gend Med 2010;7:402-13.
6. Merline AC, O'Malley PM, Schulenberg JE, Bachman JG, Johnston LD. Substance use among adults 35 years of age: prevalence, adulthood predictors, and impact of adolescent substance use. Am J Public Health 2004;94:96-102.
7. Johnston LD, O'Malley PM, Bachman JG, Schulenberg JE. Monitoring the Future national results on adolescent drug use: overview of key findings, 2011. Ann Arbor (MI): Institute for Social Research, The University of Michigan; 2012. Available at: http://monitoringthefuture.org/pubs/mono graphs/mtf-overview2011. pdf. Retrieved June 14, 2012.
8. Cash SJ, Wilke DJ. An ecological model of maternal substance abuse and child neglect: issues, analyses, and recommendations. Am J Orthopsychiatry 2003;73:392-404.
9. Center for Substance Abuse Treatment. Substance abuse treatment and family therapy. Treatment Improvement Protocol (TIP) Series, No. 39. DHHS Publication No. (SMA) 05-4006. Rockville (MD): Substance Abuse and Mental Health Services Administration; 2004. Available at: http://www.ncbi.nlm.nih.gov/books/ NBK64265/pdf/TOC.pdf. Retrieved June 14, 2012.
10. Substance Abuse and Mental Health Services Administration. The DAWN report: highlights of the 2009 Drug Abuse Warning Network (DAWN) findings on drug-related emergency department visits. Rockville (MD): SAMHSA; 2010. Available at: http://www.oas.samhsa.gov/2k10/DAWN034/EDHighlights.htm. Retrieved June 14, 2012.
11. Kaltenbach K, Berghella V, Finnegan L. Opioid dependence during pregnancy: effects and management. Obstet Gynecol Clinics N Am 1998;25:139-51.
12. Food and Drug Administration. FDA drug safety communication: prescription acetaminophen products to be limited to 325 mg per dosage unit; boxed warning will highlight potential for severe liver failure. Silver Spring (MD): FDA; 2011. Available at: http://www.fda.gov/Drugs/DrugSafety/ucm239821.htm. Retrieved June 14, 2012.
13. Licata SC, Rowlett JK. Abuse and dependence liability of benzodiazepine-type drugs: GABA(A) receptor modulation and beyond. Pharmacol Biochem Behav 2008;90:74-89.
14. Ewing H. A practical guide to intervention in health and social services with pregnant and postpartum addicts and alcoholics: theoretical framework, brief screening tool, key interview questions, and strategies for referral to recovery resources. Martinez (CA): The Born Free Project, Contra Costa County Department of Health Services; 1990.
15. Tenore PL. Advanced urine toxicology testing. J Addict Dis 2010;29:436-48.
16. Jacobs WS, DuPont R, Gold MS. Drug testing and the DSM-IV. Psychiatric Ann 2000;30:583-8.
17. Motivational interviewing: a tool for behavioral change. ACOG Committee Opinion No. 423. American College of Obstetricians and Gynecologists. Obstet Gynecol 2009;113:243-6.
18. Drug addiction treatment act of 2000, Pub. L. No. 106-310 § 3502, 114 Stat. 1223-7. (2000).
19. Center for Substance Abuse Treatment. Medicationassisted treatment for opioid addiction in opioid treatment programs. Treatment Improvement Protocol (TIP) Series, No. 43. DHHS Publication No. (SMA) 05-4048. Rockville (MD): Substance Abuse and Mental Health Services Administration; 2005. Available at: http://www.ncbi.nlm. nih.gov/books/NBK64164/pdf/TOC.pdf. Retrieved June 14, 2012.
20. Hernandez SH, Nelson LS. Prescription drug abuse: insight into the epidemic. Clin Pharmacol Ther 2010;88:307-17.
21. Pedapati EV, Bateman ST. Toddlers requiring pediatric intensive care unit admission following at-home expo- sure to buprenorphine/naloxone. Pediatr Crit Care Med 2011;12:e102-7.
22. Patient testing: ethical issues in selection and counseling. ACOG Committee Opinion No. 363. American College of Obstetricians and Gynecologists. Obstet Gynecol 2007; 109:1021-3.
23. Opioid abuse, dependence, and addiction in pregnancy. Committee Opinion No. 524. American College of Obstetricians and Gynecologists. Obstet Gynecol 2012;119: 1070-6.
24. Taillac C, Goler N, Armstrong MA, Haley K, Osejo V. Early start: an integrated model of substance abuse intervention for pregnant women. Perm J 2007;11(3):5-11.
25. Paulozzi LJ, Kilbourne EM, Desai HA. Prescription drug monitoring programs and death rates from drug overdose. Pain Med 2011;12:747-54.
26. Pond SM, Kreek MJ, Tong TG, Raghunath J, Benowitz NL. Altered methadone pharmacokinetics in methadonemaintained pregnant women. J Pharmacol Exp Ther 1985; 233:1-6.
27. Center for Substance Abuse Treatment. Pain management without psychological dependence: a guide for healthcare providers. Substance Abuse in Brief Fact Sheet. Rockville (MD): Substance Abuse and Mental Health Services Administration; 2006. Available at: http://www.kap.samhsa. gov/products/ brochures/pdfs/saib-0401.pdf. Retrieved June 14, 2012.
28. General Accounting Office. Prescription drugs: state monitoring programs provide useful tool to reduce diversion. Washington, DC: GAO; 2002. Available at: http://www.gao. gov/assets/240/234687.pdf. Retrieved June 14, 2012.
29. American Society of Interventional Pain Physicians. Facts on NASPER: National Drug control Policy and Prevention of Prescription Drug Abuse Reauthorization Act of 2010. Paducah (KY): ASIPP; 2010. Available at: http://www. nasper.org/database.htm. Retrieved June 14, 2012.
30. National All Schedules Prescription Electronic Reporting Act of 2005, Pub. L. No. 109-60, 119 Stat. 1979.
31. Alliance of States with Prescription Monitoring Programs. PMP access. Available at: http://www.pmpalliance.org/con tent/pmp-access. Retrieved June 19, 2012.si